Consensus Progyny, Inc.

Equities

PGNY

US74340E1038

Delayed Nasdaq Other stock markets 01:16:13 03/05/2024 am IST			5-day change	1st Jan Change
31.86 ^USD	-1.33%		-1.91%	-14.25%

12/03	Transcript : Progyny, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 10:15 AM
05/03	Progyny Insider Sold Shares Worth $403,260, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Progyny, Inc.

Price target over the last 5 years

History of analyst recommendation changes

95e9a0133610b6e6dcc8f1a.lk2tlI7hADLbBE3cESWa2pjmuJ25ulAedxQeO3paDRs.pzrI8N2nRGixKR6FX3X1js2O7_SP0T1sNnF7bTcjRUHaBZ7fvZRRf4JUOg~e3bd07c7e2464eae1c02504bda04f75b

Analyst Recommendations on Progyny, Inc.

KeyBanc Adjusts Price Target on Progyny to $43 From $45, Maintains Overweight Rating	28/02	MT
Truist Securities Adjusts Price Target on Progyny to $47 From $52, Maintains Buy Rating	08/11	MT
KeyBanc Adjusts Progyny Price Target to $45 From $50, Maintains Overweight Rating	08/11	MT
JPMorgan Adjusts Progyny Price Target to $57 From $58, Maintains Overweight Rating	09/23/09	MT
Canaccord Genuity Initiates Progyny With Buy Rating, Price Target is $46	27/23/27	MT
Cantor Fitzgerald Raises Price Target on Progyny to $48 From $45, Maintains Overweight Rating	14/23/14	MT
Truist Securities Raises Progyny Price Target to $52 From $48, Maintains Buy Rating	10/23/10	MT
Keybanc Adjusts Price Target on Progyny to $50 From $45, Keeps Overweight Rating	04/23/04	MT
BTIG Starts Progyny at Buy With $50 Price Target	22/23/22	MT
Cantor Fitzgerald Adjusts Price Target on Progyny to $45 From $44, Maintains Overweight Rating	09/23/09	MT
Cantor Fitzgerald Initiates Progyny at Overweight With $44 Price Target	21/23/21	MT
SVB Securities Downgrades Progyny to Market Perform From Outperform, Adjusts Price Target to $34 From $59	05/23/05	MT
KeyBanc Capital Markets Adjusts Price Target on Progyny to $45 From $55, Maintains Overweight Rating	19/22/19	MT
JPMorgan Chase Adjusts Price Target on Progyny to $62 From $78, Maintains Overweight Rating	18/22/18	MT
Berenberg Bank Adjusts Progyny Price Target to $55 From $58, Maintains Buy Rating	04/22/04	MT
KeyBanc Starts Progyny at Overweight With $55 Price Target	16/22/16	MT
Truist Securities Starts Progyny at Buy With $56 Price Target	07/22/07	MT
Berenberg Bank Adjusts Progyny's Price Target to $58 From $66, Maintains Buy Rating	14/22/14	MT
Berenberg Bank Adjusts Progyny's Price Target to $66 From $70, Maintains Buy Rating	06/22/06	MT
Berenberg Bank Adjusts Progyny's Price Target to $70 From $71, Maintains Buy Rating	02/22/02	MT
Berenberg Bank Adjusts Progyny's Price Target to $71 From $80, Maintains Buy Rating	19/22/19	MT
Jefferies Starts Progyny at Buy with $60 Price Target	02/21/02	MT
Citigroup Downgrades Progyny to Neutral From Buy, Adjusts Price Target to $64 From $60	22/21/22	MT
PROGYNY : JPMorgan Adjusts Progyny PT to $79 From $65, Maintains Overweight Rating	22/21/22	MT
PROGYNY : Berenberg Starts Progyny at Buy With $81 Price Target	30/21/30	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

32.29 USD

Average target price

46.9 USD

Spread / Average Target

+45.25%

High Price Target

51 USD

Spread / Highest target

+57.94%

Low Price Target

43 USD

Spread / Lowest Target

+33.17%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Progyny, Inc.

KeyBanc Capital Markets
Truist Securities
JPMorgan Chase
Canaccord Genuity
Cantor Fitzgerald
BTIG
SVB Securities LLC
Berenberg Bank
Jefferies & Co.
Citigroup
Barclays
Guggenheim
SVB Leerink
BofA Securities

Ratings for Progyny, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar